Get the latest news alerts: at Twitter.
Local Tech Wire
RESEARCH TRIANGLE PARK, N.C. – Researchers from UNC-Chapel Hill, Duke and N.C. State will team up to develop what they call “more powerful” clinical trials for cancer treatments with a$12.5 million in federal funding.
The team received a five-year grant from the for its work.
The focus will be on treatments that are geared more toward personalized therapies and also developing them more quickly.
Called “Statistical Methods for Cancer Clinical trials,” the grant is one of the larger ones awarded by the institute.
Principal investigators for the program are:
• Michael Kosorok, Ph.D., professor and chair of the biostatistics department of the UNC Gillings School of Global Public Health
• Marie Davidian, Ph.D., William Neal Reynolds Professor of Statistics and director of the Center for Quantitative Sciences in Biomedicine at NC State
• Stephen George, Ph.D., professor of biostatistics at Duke.
Co-principal investigators are: Joseph Ibrahim, Ph.D., Alumni Distinguished Professor of Biostatistics and director of the Center for Innovative Clinical Trials at UNC; Sin-Ho Jung, Ph.D., professor of biostatistics at Duke; and Anastasios Tsiatis, PhD, Drexel Professor of Statistics at NC State.
First year funding will top $2.5 million.